Constipation-predominant Irritable Bowel Syndrome Clinical Trial
Official title:
The Efficacy and Safety of a Chinese Herbal Medicine for the Constipation-predominant Irritable Bowel Syndrome (IBS-C): a Double-blinded, Placebo-controlled, Randomized Pilot Clinical Trial
This double-blind, placebo-controlled randomized pilot clinical trial will test the hypothesis that granules of CDD-2105, a Chinese herbal medicine formula, will have efficacy in alleviating constipation and abdominal pain in individuals with IBS-C. Participants (n=78) will be randomly assigned to the treatment or placebo group in a 1:1 ratio, followed by 4 weeks of intervention and 4 weeks of follow-up.
This double-blind, placebo-controlled randomized pilot clinical trial will test the hypothesis that granules of CDD-2105, a Chinese herbal medicine formula, will have efficacy in alleviating constipation and abdominal pain in individuals with IBS-C. Participants (n=78) will be randomly assigned to the treatment or placebo group in a 1:1 ratio, followed by 4 weeks of intervention and 4 weeks of follow-up.Primary Objective: To determine the efficacy and safety of CDD-2105 granules for treating IBS-C. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00742872 -
Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
|
Phase 3 | |
| Completed |
NCT05164861 -
Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations
|
N/A | |
| Withdrawn |
NCT05321953 -
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation
|
N/A | |
| Completed |
NCT01085643 -
Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
|
N/A | |
| Completed |
NCT03150212 -
Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype
|
N/A | |
| Recruiting |
NCT05757037 -
Laser Acupuncture on Irritable Bowel Syndrome in Females
|
N/A | |
| Completed |
NCT05392439 -
Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome
|
N/A | |
| Not yet recruiting |
NCT05921383 -
Anorectal Manometry of Patients With Constipation Predominant IBS
|
||
| Recruiting |
NCT05134584 -
Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
|
Phase 4 | |
| Terminated |
NCT03336034 -
Assessment of Responsiveness to Treatment by Experience Sampling Method
|
||
| Not yet recruiting |
NCT04666155 -
MOWOOT Device Treatment for Adults With Chronic Constipation
|
N/A | |
| Not yet recruiting |
NCT05941650 -
To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT00945334 -
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT00912301 -
Cheno Effect on Transit in Health and IBS-C
|
Phase 2 | |
| Terminated |
NCT00607971 -
Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
|
Phase 3 |